Farwell MD, Clark AS, Mankoff DA: How imaging biomarkers can inform clinical trials and clinical practice in the era of targeted cancer therapy. JAMA Oncology 1(4): 421-422, 2015.
Mankoff DA, Farwell MD, Clark AS, Pryma DA: How imaging can impact clinical trial design: molecular imaging as a biomarker for targeted cancer therapy. Cancer J. 21(3): 218-224, 2015.
Farwell MD, Pryma DA, Mankoff DA: PET/CT imaging in cancer: Current applications and future directions. Cancer 120(22): 3433-3445, 2014.
Farwell MD, Chong DJ, Iida Y, Bae SA, Easwaramoorthy B, Ichise M: Imaging P-glycoprotein function in rats using [(11)C]-N-desmethyl-loperamide. Ann Nucl Med. 27(7): 618-624, 2013.
Harris PE, Farwell MD, Ichise M: PET quantification of pancreatic VMAT 2 binding using (+) and (-) enantiomers of [18F]FP-DTBZ in baboons. Nucl Med Biol. 40(1): 60-64, 2013.
Lefort L, Crane TW, Farwell MD, Baruch DM, Kaeuper JA, Lachicotte RJ, Jones WD: Synthesis and Reactions of Cp-Linked Phosphine Complexes of Rhodium. Organometallics 17(18): 3889-3899, 1998.
back to top
Last updated: 10/27/2016
The Trustees of the University of Pennsylvania